Lunchtime Learning Series
45-minute lunchtime opportunities for new learning and Q&A
A 45-minute lunchtime session offering new learning opportunities and Q&A – held every third Tuesday of the month.
Online event
Those who register will be able to view a recording of the seminar after it takes place.
Participation fee
YORIAILab members, student interns, and clinical trial ambassadors : Free
Patients, patient families, and patient supporters: Free
Other than the above (non-members): 500 yen/session
Please register in the information section for each session.
Handling of recordings and materials
Lunchtime Short Seminar
-
Access to seminar recordings is available for four weeks from the date of the seminar and is limited to registered participants.
-
In accordance with the YORIAILab Guidelines for the Use of Seminar Recordings, recordings will be made publicly available six months after the seminar date to support learning and knowledge sharing. Only the presentation portion of the recording will be released; Q&A sessions and discussion segments will not be included.
-
When a recording is available for viewing, it will be indicated as "Recording" in the session listing..
-
Access to presentation materials is limited to YORIAILab members. Non-members who wish to obtain materials are encouraged to contact us individually for consideration.
-
If you reuse all or part of any publicly available seminar recording or presentation materials, please clearly indicate the source URL of the original recording. Thank you for your understanding and cooperation.
🎞️
Archives
19th
Tuesday, April 21, 2026
Making Clinical Trials Easier to Understand Through Healthcare and the Arts: A New Approach to Reducing Patient Anxiety
This session introduces freely available educational resources on clinical trials, developed in collaboration with Kyoto University of the Arts to help people with little or no prior knowledge of clinical trials understand them more easily.
Speaker: Kaori Takagi, AstraZeneca
19th
Tuesday, April 21, 2026
Making Clinical Trials Easier to Understand Through Healthcare and the Arts: A New Approach to Reducing Patient Anxiety
This session introduces freely available educational resources on clinical trials, developed in collaboration with Kyoto University of the Arts to help people with little or no prior knowledge of clinical trials understand them more easily.
Speaker: Kaori Takagi, AstraZeneca
19th
Tuesday, April 21, 2026
Making Clinical Trials Easier to Understand Through Healthcare and the Arts: A New Approach to Reducing Patient Anxiety
This session introduces freely available educational resources on clinical trials, developed in collaboration with Kyoto University of the Arts to help people with little or no prior knowledge of clinical trials understand them more easily.
Speaker: Kaori Takagi, AstraZeneca
18th
Tuesday, March 17, 2026
Rethinking PPI Through a Human Needs Model: A Patient Perspective
While the importance of Patient and Public Involvement (PPI) continues to grow, there are still aspects of dialogue between patients and researchers that remain insufficiently explored. Drawing on the experiences of a patient who has participated in PPI activities, this seminar proposes a new model of PPI inspired by fundamental human needs.
Speaker: Shunsuke Suzuki, Aizu University Graduate School / YORIAILab Intern
17th
Tuesday, February 17, 2026
Making Medicine Bottle Packaging Easier to Use: A Patient–Pharmaceutical Company Co-creation Case Study
This session presents a case study in which a workshop involving patients with lived experience and pharmaceutical company employees led to the co-creation of patient-facing materials. It also shares, from the pharmaceutical company's perspective, how key insights gained through the workshop were applied throughout the co-creation process.
Speaker: Miki Sugihara, Nippon Boehringer Ingelheim
16th
Tuesday, January 20, 2026
Experiences from Lay Summary Workshops
Share insights into the opportunities and challenges of implementing Patient and Public Involvement (PPI), drawing on experiences from a mock Lay Summary Workshop.*
*The workshop was organized by PPI JAPAN and conducted in collaboration with academic societies and other partner organizations.
Speaker: Akiko Tamamori, Chugai
15th
Tuesday, December 16, 2025
Patient and Public Involvement in the Healthcare Policymaking Process
This session explains the fundamentals of public policymaking and explores why the voices of patients and people with lived experience are often underrepresented in healthcare policy. It examines the importance of participation from the perspectives of democracy, lived experience, and improving the quality of policymaking. The session also introduces the initiatives of the Health and Global Policy Institute (HGPI) to promote meaningful patient and public participation in the healthcare policymaking process, together with practical examples of current activities.
Speaker: Shunichiro Kurita, Health Global Policy Institute
14th
Tuesday, November 18, 2025
Health Technology Assessment (HTA)
Health Technology Assessment (HTA) is a relatively new approach that has recently been introduced into Japan’s healthcare system. This session explains how HTA evaluates the value of new medicines from a broader societal perspective—beyond what is assessed during clinical trials and regulatory review—and how these assessments are used to support decision-making within the healthcare system.
Speaker: Tatsuki Ishizuka, Nippon Boehringer Ingelheim / Keio University Graduate School
13th
Tuesday, November 4, 2025
Patient Experience Data II
The use of Patient Experience Data (PED) in regulatory decision-making and Health Technology Assessment (HTA) is steadily increasing in many countries. Building on the introductory session on PED, this seminar explores the latest discussions, emerging best practices, and the key challenges that must be addressed to further practices.
Speaker: Nobutaka Yagi, YORIAILab / Nippon Boehringer Ingelheim
Open Access Recordings ➡️
12th
Quality Management Using A Risk-Based Approach
This session introduces the Risk-Based Approach (RBA), a framework for risk management in clinical trials. It explains the key concepts and practical steps involved in implementing RBA, as well as the roles and responsibilities of RBA professionals.
Speaker: Yasuko Ishiguchi, A2 Healthcare
11th
Pediatric Clinical Trials
Pediatric clinical trials are essential for developing medicines that are safe and effective for children. This session explores why these trials are so important, and shares real-world examples of the challenges encountered in practice.
Speaker: Shinobu Nakashima, Fukuoka City Children's Hospital
10th
Work of CRAs
Have you ever wondered what a Clinical Research Associate (CRA) does? This session provides an easy-to-understand introduction to the role of CRAs, their day-to-day responsibilities, and the experiences and perspectives of those working in the field.
Speaker Haruna Shibayama, Parexel International
9th
Gamification for Patients
This session introduces the fundamental principles and techniques of gamification, drawing on examples from real-world games, and explores how these approaches can help make treatment more engaging, motivating, and easier to continue.
Instructor: Hiroshi Matsuyama, Amata
8th
Connecting Clinical Trials and Patients: The Role of Clinical Research Coordinators (CRCs)
Clinical Research Coordinators (CRCs) serve as an essential link between clinical trials and the people who participate in them. This session introduces the vital role of CRCs.
Held in recognition of International Clinical Trials Day on 20 May🎈
Speaker: Ayano Miyake, St. Luke's International Hospital
7th
April 15, 2025
🎞️ 32:22
Online Communities and the Metaverse
This session explores how digital technologies are transforming our understanding of patients and creating new opportunities for patient-centered research in the digital age. This seminar was held as a pre-event for the 1st YORIAU Symposium, held on 25 April.
Instructor: Toru Sugimoto, Buzzreach
5th
Drug Loss in Japan: Current Challenges and Future Outlook II
Why is drug loss occurring in Japan, and how does the situation differ from that in other countries? This session explores the underlying causes of drug loss, compares Japan’s experience with international trends, and discusses future directions.
Speaker: Kotone Matsuyama, YORIAILab / Department of Medical Management, Nippon Medical School
4th
Basic Clinical Statistics I
This introductory session explains the basic principles of clinical trial design and the statistical methods used to analyze different types of clinical data.
Speaker: Nobutaka Yagi, YORIAILab / Nippon Boehringer Ingelheim
3rd
Lay Communication
As interest grows in making medical research more accessible to patients and the public, effective communication has become increasingly important—not only for clinical trial lay summaries but also for communicating the findings of a wide range of medical research. This session explores the principles of lay communication and introduces practical examples of how scientific information can be translated for patients and the public.
Speaker: Hiroyuki Wadahama, Kyoto University iPS Cell Research Institute
2nd time
Drug Loss in Japan: Current Challenges and Future Outlook I
This introductory session explores the key factors contributing to drug loss, compares Japan’s situation with international trends, and discusses the future outlook.
Speaker: Kotone Matsuyama, YORIAILab / Department of Medical Management, Nippon Medical School
1st [Repeat]
Patient Experience Data
This session explores how Patient Experience Data (PED) can provide meaningful evidence, the importance of patient engagement in generating and interpreting PED, and how patient perspectives can contribute to decision-making across healthcare, and discuss the future outlook.
Speaker: Nobutaka Yagi, YORIAILab / Nippon Boehringer Ingelheim
1st
Patient Experience Data
This session explores how Patient Experience Data (PED) can provide meaningful evidence, the importance of patient engagement in generating and interpreting PED, and how patient perspectives can contribute to decision-making across healthcare, and discuss the future outlook.
Speaker: Nobutaka Yagi, YORIAILab / Nippon Boehringer Ingelheim